Source: Eur Respir J, 58 (2) 2003157; 10.1183/13993003.03157-2020
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Yan Hui Giam, Amelia Shoemark, James D. Chalmers. Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism. Eur Respir J, 58 (2) 2003157; 10.1183/13993003.03157-2020

Member's Comments

No comment yet.

Related content which might interest you: Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 459s Year: 2003 Epithelial pIgR: A new player in idiopathic pulmonary fibrosis? Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination? Source: Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019 Year: 2019 Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Platelets: a potential role in chronic respiratory diseases? Source: Eur Respir Rev, 30 (161) 210062; 10.1183/16000617.0062-2021 Year: 2021 Severe lung inflammation is a feature of IPF Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Pulmonary fibrosis: key features and challenges Source: International Congress 2015 – PG8 Airway and lung fibrosis Year: 2015 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The role of circulating mitochondrial DNA in modulating airway inflammation of chronic obstructive pulmonary disease Source: International Congress 2014 – Cell biology 2014 Year: 2014 Lung inflammation in cystic fibrosis: an overlooked therapeutic target? Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 A role for the mesothelium in restrictive chronic lung allograft dysfunction? Source: International Congress 2017 – The ongoing struggle: insights into chronic lung allograft dysfunction (CLAD) Year: 2017 Neutrophil extracellular traps (NETs) in COPD: A potential novel mechanism for host damage in acute exacerbations Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015